{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:50:11Z","timestamp":1787759411747,"version":"build-2784847793"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010804","name":"Faculty of Medicine, Prince of Songkla University","doi-asserted-by":"publisher","award":["55-201-14-1-1"],"award-info":[{"award-number":["55-201-14-1-1"]}],"id":[{"id":"10.13039\/501100010804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ejps.2019.05.018","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T21:05:20Z","timestamp":1558731920000},"page":"104940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Population pharmacokinetics and Monte Carlo simulations of sulbactam to optimize dosage regimens in patients with ventilator-associated pneumonia caused by Acinetobacter baumannii"],"prefix":"10.1016","volume":"136","author":[{"given":"Sutep","family":"Jaruratanasirikul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajanarat","family":"Nitchot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wibul","family":"Wongpoowarak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maseetoh","family":"Samaeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monchana","family":"Nawakitrangsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2019.05.018_bb0005","first-page":"354","article-title":"Quick bioanalytical method of quantification and validation of sulbactam in plasma using high performance liquid chromatography","volume":"7","author":"Abu-Shandi","year":"2009","journal-title":"Cent. Eur. J. Chem."},{"key":"10.1016\/j.ejps.2019.05.018_bb0010","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1128\/AAC.36.6.1171","article-title":"Pulmonary disposition of antimicrobial agents: methodological considerations","volume":"36","author":"Baldwin","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2019.05.018_bb0015","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1214\/aoms\/1177706645","article-title":"A note on the generation of random normal deviates","volume":"29","author":"Box","year":"1958","journal-title":"Ann. Math. Stat."},{"key":"10.1016\/j.ejps.2019.05.018_bb0020","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ijantimicag.2008.10.005","article-title":"Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis","volume":"33","author":"Brink","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejps.2019.05.018_bb0025","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1128\/AAC.01468-05","article-title":"Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis","volume":"50","author":"Buerger","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2019.05.018_bb0030","series-title":"First Comprehensive Penicillin-binding Protein (PBP) Occupancy Patterns of Beta-Lactams in Acinetobacter baumannii (AB)","author":"Bulitta","year":"2018"},{"key":"10.1016\/j.ejps.2019.05.018_bb0035","doi-asserted-by":"crossref","first-page":"e1225","DOI":"10.1016\/j.ijid.2013.07.014","article-title":"Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis factors","volume":"17","author":"Chaari","year":"2013","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ejps.2019.05.018_bb0040","series-title":"Monte Carlo Simulation for the Pharmaceutical Industry: Concepts, Algorithms and Case Studies","author":"Chang","year":"2011"},{"key":"10.1016\/j.ejps.2019.05.018_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0934-8840(96)80150-2","article-title":"Pharmacokinetics of antimicrobial agents in the respiratory tract","volume":"284","author":"Cruciani","year":"1996","journal-title":"Zentralbl Bakteriol"},{"key":"10.1016\/j.ejps.2019.05.018_bb0050","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1128\/AAC.01559-10","article-title":"Meropenem penetration into epithelial lining fluid in mice and humans and delineation of exposure targets","volume":"55","author":"Drusano","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2019.05.018_bb0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11908-009-0003-9","article-title":"Pharmacokinetics of antibiotics or antifungal drugs in intensive care units","volume":"11","author":"Dufour","year":"2009","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.ejps.2019.05.018_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/653120","article-title":"Treatment of Acinetobacter infections","volume":"51","author":"Fishbain","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2019.05.018_bb0065","first-page":"4","article-title":"Acinetobacter pneumonia: a review","volume":"9","author":"Hartzell","year":"2007","journal-title":"Medscape Gen. Med."},{"key":"10.1016\/j.ejps.2019.05.018_bb0070","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/AAC.48.5.1586-1592.2004","article-title":"In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains","volume":"48","author":"Higgins","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2019.05.018_bb0075","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3201\/eid0808.020014","article-title":"Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan","volume":"8","author":"Hsueh","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ejps.2019.05.018_bb0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijantimicag.2011.04.019","article-title":"Pharmacodynamics of meropenem in critically ill patients with febrile neutropenia and bacteraemia","volume":"38","author":"Jaruratanasirikul","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejps.2019.05.018_bb0085","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ijantimicag.2012.07.014","article-title":"Pharmacodynamics of doripenem in critically ill patients with ventilator-associated Gram-negative bacilli pneumonia","volume":"40","author":"Jaruratanasirikul","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejps.2019.05.018_bb0090","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1128\/AAC.00342-13","article-title":"Pharmacodynamics modeling to optimize dosage regimens of sulbactam","volume":"57","author":"Jaruratanasirikul","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2019.05.018_bb0095","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jac\/47.4.421","article-title":"The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients","volume":"47","author":"Joynt","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2019.05.018_bb0100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/cc13775","article-title":"Ventilator-associated pneumonia in the ICU","volume":"18","author":"Kalanuria","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejps.2019.05.018_bb0105","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1128\/AAC.01578-08","article-title":"Comparison of the pharmacodynamics of biapenem in bronchial epithelial lining fluid in healthy volunteers given half-hour and three-hour intravenous infusions","volume":"53","author":"Kikuchi","year":"2009","journal-title":"Antimicrob. Agent. Chemother."},{"key":"10.1016\/j.ejps.2019.05.018_bb0110","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/CMR.00051-05","article-title":"Ventilator-associated pneumonia: diagnosis, treatment, and prevention","volume":"19","author":"Koenig","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejps.2019.05.018_bb0115","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0098-1354(97)00005-7","article-title":"Heuristic random optimization","volume":"22","author":"Li","year":"1998","journal-title":"Comput. Chem. Eng."},{"key":"10.1016\/j.ejps.2019.05.018_bb0120","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/502091","article-title":"Completely resistant Acinetobacter baumannii strains","volume":"23","author":"Mahgoub","year":"2002","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.ejps.2019.05.018_bb0125","series-title":"Numerical Methods for Computer Science, Engineering and Mathematics","author":"Mathews","year":"1987"},{"key":"10.1016\/j.ejps.2019.05.018_bb0130","series-title":"Simulation for Designing Clinical Trials: A Pharmacokinetic-Pharmacodynamic Modelling Prespective","first-page":"31","article-title":"Defining covariate distribution models for trial simulation","author":"Mould","year":"2007"},{"key":"10.1016\/j.ejps.2019.05.018_bb0135","series-title":"Antimicrobial Pharmacodynamics in Theory and Clinical Practice","first-page":"21","article-title":"Applying pharmacodynamics for susceptibility breakpoint selection and susceptibility testing","author":"Mouton","year":"2007"},{"key":"10.1016\/j.ejps.2019.05.018_bb0140","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/AAC.04808-14","article-title":"Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii","volume":"59","author":"Penwell","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2019.05.018_bb0145","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.coph.2017.09.019","article-title":"Considerations for effect site pharmacokinetics to estimate drug exposure: concentrations of antibiotics in the lung","volume":"36","author":"Rodvold","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejps.2019.05.018_bb0150","first-page":"638","article-title":"The binding of antibiotics to serum proteins","volume":"25","author":"Rolinson","year":"1965","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2019.05.018_bb0155","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/cc9091","article-title":"Insufficient \u03b2-lactam concentrations in the early phase of severe sepsis and septic shock","volume":"14","author":"Taccone","year":"2010","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejps.2019.05.018_bb0160","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s11908-011-0203-y","article-title":"Appropriate antibiotic dosage levels in the treatment of severe sepsis and septic shock","volume":"13","author":"Taccone","year":"2011","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.ejps.2019.05.018_bb0165","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1378\/chest.11-1671","article-title":"Subtherapeutic initial \u03b2-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations","volume":"142","author":"Udy","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ejps.2019.05.018_bb0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/11539220-000000000-00000","article-title":"The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients","volume":"50","author":"Ulldemolins","year":"2011","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2019.05.018_bb0175","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/AAC.34.6.958","article-title":"Penetration of ampicillin and sulbactam in the lower airways during respiratory infections","volume":"34","author":"Valcke","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2019.05.018_bb0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ccc.2010.09.006","article-title":"Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock","volume":"27","author":"Varghese","year":"2011","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.ejps.2019.05.018_bb0185","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/0924-8579(95)00058-5","article-title":"Stability of \u03b2-lactamase inhibitors and \u03b2-lactam antibiotics in parenteral dosage forms and in body fluids and tissue homogenates: a comparative study of sulbactam, clavulanic acid, ampicillin and amoxycillin","volume":"6","author":"Wildfeuer","year":"1996","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejps.2019.05.018_bb0190","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/clinids\/24.3.494","article-title":"Beta-lactamase inhibition and in vitro activity of sulbactam and sulbactam\/cefoperazone","volume":"24","author":"Williams","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2019.05.018_bb0195","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ijantimicag.2014.02.012","article-title":"Pharmacokinetic\/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models","volume":"43","author":"Yokoyama","year":"2014","journal-title":"Int. J. Antimicrob. Agents"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719301952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719301952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T23:42:28Z","timestamp":1569022948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098719301952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":39,"alternative-id":["S0928098719301952"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2019.05.018","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population pharmacokinetics and Monte Carlo simulations of sulbactam to optimize dosage regimens in patients with ventilator-associated pneumonia caused by Acinetobacter baumannii","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2019.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104940"}}